1. Efficacy and safety of immune checkpoint inhibitors in recurrent or metastatic head and neck squamous cell carcinoma: A systematic review and meta‐analysis of randomized clinical trials
   Shoutao Dang et al, 2023, Cancer Medicine CrossRef
2. Safety and feasibility of minimally invasive gastrectomy after neoadjuvant immunotherapy for locally advanced gastric cancer: a propensity score-matched analysis in China
   Hao Cui et al, 2023, Gastroenterology Report CrossRef
3. Engineered biological nanoparticles as nanotherapeutics for tumor immunomodulation
   Juwita N. Rahmat et al, 2024, Chemical Society Reviews CrossRef
4. Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study
   Margherita Rimini et al, 2024, Targeted Oncology CrossRef
5. Structure-Guided Discovery of PD-1/PD-L1 Interaction Inhibitors: Peptide Design, Screening, and Optimization via Computation-Aided Phage Display Engineering
   Tien-Sheng Tseng et al, 2024, Journal of Chemical Information and Modeling CrossRef
6. Chronic immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors: a systematic review
   Carly C Barron et al, 2023, Journal for ImmunoTherapy of Cancer CrossRef
7. Non‑coding RNA: A promising diagnostic biomarker and therapeutic target for esophageal squamous cell carcinoma (Review)
   Longze Zhang et al, 2024, Oncology Letters CrossRef